AI assistant
Sending…
PALISADE BIO, INC. — Director's Dealing 2010
Jul 12, 2010
35274_dirs_2010-07-12_98346eb9-0241-4dc1-809b-41dee6cb585f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2010-07-08
Reporting Person: CONRON JOHN (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-07-08 | Common Stock | A | 10948 | — | Acquired | 62312 | Direct |
Footnotes
F1: On July 8, 2010, Reporting Person was issued 7,481 common shares. The issuance was previously approved on March 30, 2010 by
the Issuers Compensation Committee as part of Reporting Person's 2009 incentive bonus award. The common shares awarded may
not be sold by Reporting Person for a period of five years unless there is a "change of control" or termination of
employment.
More from PALISADE BIO, INC.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 11